《血液学杂志》.2005年.第7期
......
- Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche
- Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate
- Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 ge
- Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the
- BMP4 and Madh5 regulate the erythroid response to acute anemia
- Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics
- In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopo
- Identification of Lin–Sca1+kit+CD34+Flt3– short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated tr
- Tissue factor activity in whole blood
- Hematopoietic cells regulate the angiogenic switch during tumorigenesis
- Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of diff
- The development of imatinib as a therapeutic agent for chronic myeloid leukemia
- Vessel wall–derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells
- A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice
- VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly
- Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunothera
- Ly49Q defines 2 pDC subsets in mice
- Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
- Tumor protein D52(TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI
- Cell surface–associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein
- Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization
- Isolation and characterization of human antigen-specific TCR+ CD4-CD8- double-negative regulatory T cells
- Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation
- Triggering of OX40(CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with G
- CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells
- Abnormal interleukin-7 function in common variable immunodeficiency
- CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
- Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2
- Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
- Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity
- High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma
- Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11
- MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-B-dependent proliferative advantage and resistance against FAS-induce
- Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like d
- Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell
- The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis
- CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma
- Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of
- Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells
- RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518
- The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis
- Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study
- z-VAD-fmk augmentation of TNF-stimulated neutrophil apoptosis is compound specific and does not involve the generation of reactive oxygen sp
- Monokine induced by interferon- is induced by receptor activator of nuclear factor B ligand and is involved in osteoclast adhesion and migra
- Leydig cell injury as a consequence of an acute graft-versus-host reaction
- Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States
- Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission
- Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP–sialic a
- Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allo
- Leydig cell injury as a consequence of an acute graft-versus-host reaction
- Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly pro
- Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization
- Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience